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Abstract
Background
The joint effect of the interaction of alcohol intake, hepatitis B virus (HBV) and hepatitis C
virus (HCV) on the risk of cirrhosis is still unexplored because a large sample size is required
for this investigation.
Objective
Evaluation of interaction of HBV, HCV and alcohol abuse on the risk of cirrhosis.
Design
We analysed 12,262 consecutive patients with chronic liver disease of various aetiologies refer-
ring to 95 Italian liver units in 2001 or 2014. To evaluate the interaction between alcohol abuse,
HBV infection, and HCV infection, patients unexposed to either factors were used as reference
category. Adjustment for BMI and age was done by multiple logistic regression analysis.
Results
Females were older than males (p<0.01) and less frequently showed HBV and alcoholic
aetiology (p<0.01). In both sexes, an overtime increasing age and an increasing proportion
of subjects with liver cirrhosis was observed, reflecting a better survival (0.01).
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An additive interaction is observed in females: the O.R. generated by the simultaneous
presence of HBV, HCV, and alcohol (5.09; 95% C.I. 1.06–24.56) exceeds the sum (4.14) of
the O.R. generated by a single exposure (O.R. = 0.72 for HBsAg positivity, OR = 1.34 for anti-
HCV positivity, and O.R. = 2.08 for alcohol intake). No interaction is observed in male sex.
Conclusions
The observed gender difference suggests that the simultaneous presence of HBV/HCV
coinfection and risky alcohol intake enhances the mechanism of liver damage to a greater
extent in females than in males.
Introduction
Chronic hepatitis B (HBV) infection, chronic hepatitis C virus (HCV) infection, and risky
alcohol intake are the main risk factors for chronic liver disease worldwide. Chronic hepatitis
due to dual HBV/HCV infection more likely progresses to liver cirrhosis as compared to
patients with single viral infection [1–4]. Besides, in subjects with a risky alcohol intake, coexis-
tence of HCV infection [5–9] or HBV infection [9] strongly increases the risk of cirrhosis
development. Studies assessing the effect of coexistence of HBV, HCV, and alcohol intake on
the progression of chronic hepatitis to liver cirrhosis are lacking, most probably because the
simultaneous presence of these three factors in the same patient is infrequent and thus large
sample size is required to prove such potential effect.
Pooling the cases recruited in two national surveys [10,11] performed in Italy in 2001 and
2014, to assess clinical features of chronic liver diseases, we gathered a total sample of 12,262
subjects. This large sample size allows us the opportunity for estimating the interactions, if any,
between alcohol intake, HBV infection, and HCV infection on the risk of cirrhosis by gender.
Materials and methods
Ethics statement
This study (Extensive protocol, participating centers and summary grid) was formally and
definitively approved by the Ethics Committee of the Coordinating Center (Prof. Piero Luigi
Almasio), Ethics Committee of the University Hospital (Azienda Ospedaliera Universitaria-
Policlinico) "P. Giaccone" of Palermo, Italy, on December 9, 2015 (Verbal number 11/2015,
point 18.)
All procedures applied in the study were in accordance with the international guidelines,
with the standards of human experimentation of the local Ethics Committees and with the
Helsinki Declaration of 1975, revised in1983.
At the time of the first observation, each patient signed an informed consent for the collec-
tion of personal data, as designated by the Ethics Committee of the coordinating centre.
Patients who agreed to undergo liver biopsy signed an appropriate informed consent before
biopsy was performed.
The collection of personal data was made in full compliance with the Italian law on personal
data protection, and each patient gave his/her informed consent to participate.
Patients
The two national surveys have been previously described [10,11]. The first one enrolled all per-
sons consecutively referring to 79 liver units for a six months’ period in 2001 and the second
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one recruited all subjects referring to 16 hospitals liver units in 2014. Criteria of enrolment
were age over 18 years and altered either hepatic biochemistry or presence of etiologic markers
of liver damage or symptoms consistent with chronic liver disease. In both studies, the enroll-
ing liver units were scattered all over the country. Many of the 16 hospitals participating in the
second study had also taken part in the first one.
All patients were included only once at the time of first observation. For each patient, a pre-
coded questionnaire containing demographic, epidemiological and clinical data was filled out.
No patient refused to participate in the study.
The presence of serum HBsAg identified an HBV aetiology; the detection of anti-HCV an
HCV aetiology. Autoimmune chronic hepatitis and primary biliary cirrhosis were diagnosed
according to standardized international criteria [12,13]. The diagnosis of hereditary hemo-
chromatosis was based on abnormal ferritin serum values and transferrin saturation serum
values, genetic markers, or liver histology [14]. Wilson’s disease was a rare diagnosis based on
accepted criteria [15]. The presence of a metabolic syndrome was established based on
accepted criteria [16]. Abnormal serum alanine aminotransferase (ALT) values and a histolog-
ical and/or ultrasound pattern of hepatic steatosis, in the absence of other known causes of
chronic liver disease, were considered related to non-alcoholic fatty liver disease [13]. Alcohol
intake40 g/day for males and30 g/day for females for at least 5 years was considered an
etiologic factor of liver disease [17]. The diagnosis of cryptogenic chronic liver disease was
based on the absence of any viral, autoimmune or metabolic aetiology.
Chronic hepatitis was diagnosed based on liver histology, when available, or on the persis-
tence (>6 months) of abnormal ALT in the absence of clinical, biochemical, and ultrasound
markers of liver cirrhosis [18]. Liver cirrhosis was diagnosed by liver biopsy (LB) or on the
presence of characteristic clinical, biochemical, and ultrasound signs [18]. The diagnosis of
hepatocellular carcinoma (HCC) was based on histological and/or imaging findings and alfa-
1-fetoprotein serum levels, according to accepted criteria [19]. Serum HBsAg and antibody to
HCV, HDV and HIV were sought using commercial immunoenzymatic assays. The etiologic
markers of autoimmune hepatitis, PBC, iron and copper overload and liver function were
assessed by routine tests.
Statistical analysis
Crude O.R. were adjusted for the confounding effect of age and B.M.I. by multiple logistic
regression analysis. Interaction between risk factors for a given outcome may be additive or
multiplicative. Additive interaction, means that the observed joint effect of two or more factors
on the disease incidence (in this case cirrhosis), exceeds the sum of the effect of exposure to
each single factor minus 1. Multiplicative interaction means that the observed joint effect of
factors on the disease incidence exceeds the product of the effect of exposure to each single
factor.
To evaluate the interaction between alcohol abuse, HBV infection, and HCV infection,
patients enrolled in the 2001 and 2014 surveys and unexposed to these three factors were taken
as the reference category for all calculations. Thus, Reference category was represented by sub-
jects with other causes of chronic liver disease (NASH, autoimmunity, genetics, and so on).
We dichotomized alcohol intake as<3 units/day vs. 3 units/day in men, and <2 units/day
vs.2 units/day in women.
Results
Overall, 12,262 subjects were enrolled. Their baseline characteristics by sex are reported in
Table 1. The sex ratio (M/F) was 1.4. Females were more likely older (Mean age 58.7 y. vs. 52.9
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y; p<0.01). Significant inter gender differences were observed according to the three risk fac-
tors considered. The baseline characteristics of subjects by sex and year of recruitment
(Table 2) shows in both sexes an increasing age and an increasing proportion of subjects with
liver cirrhosis, reflecting a better survival.
We tested the hypothesis of an additive interaction due to the simultaneous presence of
HBV, HCV, and risky alcohol intake on the risk of progression to liver cirrhosis by sex. No
additive interaction was observed in males since O.R. for cirrhosis (adjusted for B.M.I. and
age) due to the joint exposure to HBsAg positivity, HCV positivity and 3 alcohol unit/day
was 3.56 (95% C.I. = 1.92–6.62), a value lower than the sum (5.32) of each single exposure
Table 1. Baseline characteristics of 12,262 enrolled subjects by sex.
Variables Male
(N = 7,138)
Female
(N = 5,124)
p-value
Age, years M±SD 52.9±15.1 58.7±13.7 <0.01
BMI, kg/m2 M±SD 25.4±3.5 25.1±4.2 N.S.
Risk factors, N (%): <0.01
-HBsAg positive alone or with other factor 1,265 (17.8) 559 (10.9)
-Anti-HCV positive alone or with other factor 4,647 (65.1) 3,812 (74.4)
-Alcohol intake alone or with other factor * 1,962 (29.0) 658 (12.9)
Diagnosis, N (%): N.S.
-Chronic hepatitis 5,302 (74.3) 3,808 (74.3)
-Liver cirrhosis without HCC 1,528 (21.4) 1,139 (22.2)
-Liver cirrhosis with HCC 308 (4.3) 177 (3.5)
*: 3 drinks a day for male and 2 drinks a day for females.
BMI: Body Max Index
HCC: hepatocellular carcinoma
HCC: hepatocellular carcinoma
https://doi.org/10.1371/journal.pone.0185710.t001
Table 2. Baseline characteristics of 12,262 enrolled subjects by sex and years of study.
Variables 2001 Study
(N = 9,752)
2014 Study
(n = 2,510)
Male
(N = 5,649)
Female
(N = 4,103)
p-value Male
(N = 1,489)
Female
(N = 1,021)
p-value
Age, years M±SD 51.7±15.2 58.1±13. <0.01 57.3±14.1 61.3±13.1 <0.01
BMI, kg/m2 M±SD 25.5±3.4 25.0±4.1 N.S. 26.3±3.9 25.7±4.6 <0.05
Risk factors, N (%):
- HBsAg positive alone or with other factor 934 (16.5) 377 (3.2) <0.01 332 (22.3) 182 (17.8) <0.01
-Anti-HCV positive alone or with other factor 3,747 (66.3) 3,167 (77.2) 900 (60.4) 645 (63.2)
-Alcohol intake alone or with other factor * 1,852 (32.8) 490 (11.5) 211 (14.2) 168 (16.5)
Diagnosis, N (%)
-Chronic hepatitis 4,327 (76.6) 3,138 (76.5) N.S. 975 (65.5) 670 (65.7) N.S.
-Liver cirrhosis without HCC 1,102 (19.5) 849 (20.7) 426 (28.6) 290 (28.4)
-Liver cirrhosis with HCC 220 (3.9) 116 (2.8) 88 (5.9) 61 (6.0)
*: 3 drinks a day for male and 2 drinks a day for females.
BMI: Body Max Index
HCC: hepatocellular carcinoma
https://doi.org/10.1371/journal.pone.0185710.t002
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(1.39 for HBsAg positivity, 1,17 for HCV positivity and 2.85 for risky alcohol intake) minus 1
(Table 3).
In contrast, an additive interaction was observed in female sex. In fact, O.R. for cirrhosis
due to the joint exposure to the three risk factors was 5.09 (95% C.I. = 1.06–24.56), a value
exceeding the sum (4.14) of the O.R. for cirrhosis of each single exposure (0.72, for HBsAg pos-
itivity; 1,34, for HCV positivity and 2.08 for risky alcohol intake) minus 1 (Table 4).
No additive interaction was observed when the two genders are combined for analysis: O.R.
3.3 for the joint presence of the three risk factors, but O.R. 4.5 for the sum of each separate risk
factor (data no shown).
Discussion
Several liver units have participated in both 2001 and 2014 surveys using comparable access
procedures, similar clinical approach and comparable methods. As consequence, the pool of
the two series of cases (2001 and 2014) may not be matter of concern.
To evaluate the interaction between alcohol intake and HBV/HCV infection on the risk of
cirrhosis we have used an internal control, which is the best control group. Cases (i.e. cirrhotic
patients) and controls (i.e. chronic hepatitis cases) were subjects extracted from the same pop-
ulation (i.e. subjects with chronic liver disease enrolled in 2001 and 2014) and thus exposed to
the same potential selective factors. In a case-control study, the comparability between cases
and controls is a crucial factor, which ensures the avoidance of potential selective factors
regarding the enrolment of cases and controls. Thus, the use of an internal control group may
have avoided spurious associations.
Table 3. Interaction between alcohol intake and co-factors in the progression from chronic hepatitis to cirrhosis in male patients. Crude and
Adjusted* Odds Ratio derived from multiple logistic regression analysis.
Variable Absence of
Cirrhosis
N (%)
Cirrhosis/HCC
N (%)
Crude OR
(95% CI)
Adjusted OR*
(95% CI)
HBsAg/HCV/alcohol:
HBsAg-/anti-HCV-/Alcohol intake < 3 units 490 (82.5%) 104 (17.5%) 1 1
HBsAg-/anti-HCV-/Alcohol intake 3 units 487 (60.0%) 324 (40.0%) 3.1 (2.4–4.0) 2.9 (2.2–3.8)
HBsAg +/anti-HCV-/Alcohol intake <3 units 731 (77.8%) 208 (22.2%) 1.3 (1.0–1.7) 1.4 (1.0–1.9)
HBsAg-/anti-HCV+/Alcohol intake < 3 units 2,655 (77.5%) 771 (22.5%) 1.4 (1.1–1.7) 1.2 (0.9–1.5)
HBsAg+/ant-HCV+/Alcohol intake 3 units** 40 (64.5%) 22 (35.5%) 2.6 (1.5–4.5) 3.6 (1.9–6.6)
*Adjusted for the confounding effect of age (<53 vs. 53 years) and BMI (<30 vs.30).
**No additive interaction is observed
https://doi.org/10.1371/journal.pone.0185710.t003
Table 4. Interaction between alcohol intake and co-factors in the progression from chronic hepatitis to cirrhosis in female patients. Crude and
Adjusted Odds*Ratio derived from multiple logistic regression analysis.
Variable Absence of Cirrhosis
N (%)
Cirrhosis/HCC
N (%)
Crude OR (95% CI) Adjusted OR*
(95% CI)
HBsAg/HCV/alcohol
HBsAg-/anti-HCV-/Alcohol intake < 2 units 350 (75.4%) 114 (24.6%) 1 1
HBsAg-/anti-HCV-/Alcohol intake 2 units 217 (61.6%) 135 (38.4%) 1.9 (1.4–2.6) 2.1 (1.5–2.9)
HBsAg+/anti-HCV-/Alcohol intake < 2 units 387 (82.2%) 84 (17.8%) 0.7 (0.5–0.9) 0.7 (0.5–1.0)
HBsAg-/anti-HCV+/Alcohol intake < 2 units 2,620 (75.3%) 858 (24.7%) 1.0 (0.8–1.3) 1.3 (0.7–1.1)
HBsAg+/anti-HCV+/Alcohol intake 2 units** 4 (40.0%) 6 (60.0%) 4.6 (1.3–16.6) 5.1 (1.1–24.6)
*Adjusted for the confounding effect of age (<59 vs. 59 years) and BMI (<30 vs.30).
**An additive interaction is observed
https://doi.org/10.1371/journal.pone.0185710.t004
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We acknowledge that the use as reference category of subjects with chronic liver disease not
related to HBV, HCV or risky alcohol intake might have underestimated the true effect on cir-
rhosis development of both single and simultaneous exposures evaluated in this study. For
example, the adjusted OR of cirrhosis in HBsAg positive females (anti-HCV negative/Alcohol
intake<2 Units) is only 0.7, suggesting that this category of subjects is not at higher risk of cir-
rhosis than those with other causes of chronic liver diseases (NASH, autoimmunity, genetics
and so on) enclosed in the reference category. The aim of this study, however, was not to esti-
mate the strength of association linking alcohol, HBV, and HCV with cirrhosis (data well
known), but to assess the interaction, if any, due to the contemporaneous presence of these
three exposures on the risk of cirrhosis. This aim is not affected by the type of reference cate-
gory chosen; but the magnitude of the risk results likely underestimated.
The increase in the rate of HBV-related cases observed in 2014 may be due to a referral
bias, since after 2001 highly effective treatments (adefovir plus lamivudine, entecavir and teno-
fovir) for long-term suppression of HBV replication were issued free of charge in hospital cen-
tres. The decrease of the impact of alcohol-related etiology, is attributable to the dramatic
increase in the rate of male abstainers, in line with the consistent reduction in alcohol abuse in
the last decade in Italy consequent to both to the efforts of the Italian Health Authorities to
prevent alcohol abuse and to the economic crisis of our Country reducing the likelihood of
purchasing alcoholic beverages in in the last decade.
It is well known that NASH is an important risk factor for liver cirrhosis. Adjustment for
this potential confounder has not been made, because this category of subjects was enclosed in
the reference category.
The present findings evidence that the combined presence of risky alcohol intake, HBV,
and HCV generates an additive effect on the risk of cirrhosis in females. Some lines of evidence
provide the biological plausibility for this finding. Firstly, both hepatitis viruses and alcohol
may stimulate hepatic-oxidative stress, which leads to the activation of liver fibrogenic cells,
and consequent acceleration of fibrogenesis [20]. Secondly, immune response is affected by
alcohol [21] that may also promote apoptosis in HCV infected hepatocytes [22]. There are con-
flicting reports on the interference of HBV infection with the apoptosis, most studies showing
inhibition and a minority induction, the HBV-mediated alteration of apoptosis being preva-
lently achieved via interference with cellular signaling pathways and regulation of epigenetics
HBV X protein (HBX) [23].
On the contrary, no additive effect was observed in males, as expected based on data show-
ing a progression to liver cirrhosis of both HBV [24,25] and HCV [26,27] chronic hepatitis
more likely in males than in females. This discrepancy may reflect a role of alcohol intake in
enhancing the pathogenic mechanisms of liver damage, more likely in females than in males.
In conclusion, this study shows a sex difference in liver disease progression in subjects with
simultaneous presence of HBV/HCV dual infection and history of alcohol abuse, suggesting that
females are at higher risk of liver cirrhosis than males and deserve a more careful surveillance.
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